Preprints (all types)

Status    Subject Created By Replies Views Last Post
Thread  
newBookmarkLockedFalling Human ace2 and tmprss2 polymorphisms for predicting ....
Nadica (She/Her) 0 9 by Nadica (She/Her)
Nov 21, 2024 5:04:21 GMT
Thread  
newBookmarkLockedFalling Upper Respiratory Tract Resistome exhibits SARS-CoV-2...
Nadica (She/Her) 0 10 by Nadica (She/Her)
Nov 21, 2024 5:03:49 GMT
Thread  
newBookmarkLockedFalling Clinical Features of Long COVID Patients Coinfected with...
Nadica (She/Her) 0 8 by Nadica (She/Her)
Nov 21, 2024 5:02:58 GMT
Thread  
newBookmarkLockedFalling Antibody evasiveness of SARS-CoV-2 subvariants KP.3.1.1 and
Nadica (She/Her) 0 6 by Nadica (She/Her)
Nov 20, 2024 2:28:50 GMT
Thread  
newBookmarkLockedFalling Single-cell epigenetic profiling reveals an interferon...
Nadica (She/Her) 0 4 by Nadica (She/Her)
Nov 20, 2024 2:28:03 GMT
Thread  
newBookmarkLockedFalling Chronic Viral Reactivation and Associated Host Immune Respon
Nadica (She/Her) 0 6 by Nadica (She/Her)
Nov 18, 2024 3:02:28 GMT
Thread  
newBookmarkLockedFalling SARS-CoV-2 EndoU-ribonuclease regulates RNA recombination...
Nadica (She/Her) 0 8 by Nadica (She/Her)
Nov 17, 2024 2:42:31 GMT
Thread  
newBookmarkLockedFalling Semaglutide-induced weight loss improves mitochondrial ...
Nadica (She/Her) 0 9 by Nadica (She/Her)
Nov 17, 2024 2:41:57 GMT
Thread  
newBookmarkLockedFalling Comparison of mortality and cardiovascular complications due
Nadica (She/Her) 0 7 by Nadica (She/Her)
Nov 16, 2024 6:08:33 GMT
Thread  
newBookmarkLockedFalling Manipulation of Host Cholesterol by SARS-CoV-2
Nadica (She/Her) 0 10 by Nadica (She/Her)
Nov 15, 2024 4:41:50 GMT
Thread  
newBookmarkLockedFalling Screening for SARS-CoV-2 persistence in Long COVID patients
Nadica (She/Her) 0 8 by Nadica (She/Her)
Nov 15, 2024 4:40:22 GMT
Thread  
newBookmarkLockedFalling Monovalent mRNA XBB.1.5 vaccine effectiveness against COVID-
Nadica (She/Her) 0 9 by Nadica (She/Her)
Nov 15, 2024 4:39:42 GMT
Thread  
newBookmarkLockedFalling Neutralization of recent SARS-CoV-2 variants by genetically
Nadica (She/Her) 0 7 by Nadica (She/Her)
Nov 14, 2024 4:15:29 GMT
Thread  
newBookmarkLockedFalling COMPARATIVE CHARACTERISTICS OF THE ACCUMULATION OF ...
Nadica (She/Her) 0 7 by Nadica (She/Her)
Nov 14, 2024 4:14:46 GMT
Thread  
newBookmarkLockedFalling Immune Evasion, Cell-Cell Fusion, and Spike Stability of ...
Nadica (She/Her) 0 9 by Nadica (She/Her)
Nov 14, 2024 4:11:06 GMT
Thread  
newBookmarkLockedFalling Vaccine-induced and hybrid immunity against SARS-CoV-2...
Nadica (She/Her) 0 7 by Nadica (She/Her)
Nov 14, 2024 4:09:59 GMT
Thread  
newBookmarkLockedFalling Interleukin-1 prevents SARS-CoV-2-induced membrane fusion...
Nadica (She/Her) 0 8 by Nadica (She/Her)
Nov 14, 2024 4:09:23 GMT
Thread  
newBookmarkLockedFalling Precision Phenotyping for Curating Research Cohorts of ...
Nadica (She/Her) 0 7 by Nadica (She/Her)
Nov 14, 2024 4:08:47 GMT
Thread  
newBookmarkLockedFalling Long-term serum spike protein persistence but no correlation
Nadica (She/Her) 0 8 by Nadica (She/Her)
Nov 14, 2024 4:07:52 GMT
Thread  
newBookmarkLockedFalling Descriptive epidemiology of COVID-19 outcomes in England...
Nadica (She/Her) 0 10 by Nadica (She/Her)
Nov 14, 2024 4:07:11 GMT
Thread  
newBookmarkLockedFalling Modeling the SARS-CoV-2 Epidemic and the Efficacy...
Nadica (She/Her) 0 7 by Nadica (She/Her)
Nov 14, 2024 4:06:31 GMT
Thread  
newBookmarkLockedFalling Post-SARS-CoV-2 Onset ME/CFS...
Nadica (She/Her) 0 8 by Nadica (She/Her)
Nov 14, 2024 4:05:55 GMT
Thread  
newBookmarkLockedFalling Distinct Binding Modes of Inter-Spike Cross-Linking Suggest
Nadica (She/Her) 0 9 by Nadica (She/Her)
Nov 12, 2024 3:34:51 GMT
Thread  
newBookmarkLockedFalling Increased preference for lysine over arginine in spike...
Nadica (She/Her) 0 10 by Nadica (She/Her)
Nov 12, 2024 3:34:05 GMT
Thread  
newBookmarkLockedFalling Modelling complete dynamics of SARS-CoV-2 pandemics of ...
Nadica (She/Her) 0 9 by Nadica (She/Her)
Nov 12, 2024 3:28:24 GMT
Thread  
newBookmarkLockedFalling Safety and immunogenicity of four sequential doses of NVX-..
Nadica (She/Her) 0 13 by Nadica (She/Her)
Nov 12, 2024 3:20:23 GMT
Thread  
newBookmarkLockedFalling Neutralizing Activity and Viral Escape of Pemivibart by C19.
Nadica (She/Her) 0 8 by Nadica (She/Her)
Nov 11, 2024 2:55:10 GMT
Thread  
newBookmarkLockedFalling Generation of a biosafety mouse model infection for SARS-CoV
Nadica (She/Her) 0 8 by Nadica (She/Her)
Nov 11, 2024 2:54:25 GMT
Thread  
newBookmarkLockedFalling The first report on detecting SARS-CoV-2 inside bacteria...
Nadica (She/Her) 0 8 by Nadica (She/Her)
Nov 11, 2024 1:32:38 GMT
Thread  
newBookmarkLockedFalling Integrative metagenomics and metabolomics reveal ...
Nadica (She/Her) 0 8 by Nadica (She/Her)
Nov 11, 2024 1:13:18 GMT
Thread  
newBookmarkLockedFalling Visual preferences for communicating modelling:
Nadica (She/Her) 0 7 by Nadica (She/Her)
Nov 11, 2024 1:12:38 GMT
Thread  
newBookmarkLockedFalling Follicular Bcl6 reactivity is associated with a unique...
Nadica (She/Her) 0 8 by Nadica (She/Her)
Nov 11, 2024 1:10:22 GMT
Thread  
newBookmarkLockedFalling A Modular Bacteriophage T4 Nanoparticle Platform Enables ...
Nadica (She/Her) 0 13 by Nadica (She/Her)
Nov 10, 2024 3:24:16 GMT
Thread  
newBookmarkLockedFalling Dissecting human monoclonal antibody responses from mRNA-...
Nadica (She/Her) 0 12 by Nadica (She/Her)
Nov 10, 2024 3:23:11 GMT
Thread  
newBookmarkLockedFalling SARS-CoV-2 JN.1 reveals attenuated pathogenicity and...
Nadica (She/Her) 0 13 by Nadica (She/Her)
Nov 10, 2024 3:22:25 GMT
Thread  
newBookmarkLockedFalling Persistent Health and Cognitive Impairments Up to Four Years
Nadica (She/Her) 0 19 by Nadica (She/Her)
Nov 10, 2024 3:19:43 GMT
Thread  
newBookmarkLockedFalling Precision Phenotyping for Curating Research Cohorts of...
Nadica (She/Her) 0 9 by Nadica (She/Her)
Nov 9, 2024 3:26:46 GMT
Thread  
newBookmarkLockedFalling SARS-CoV-2 infection enhancement by Amphotericin B:
Nadica (She/Her) 0 8 by Nadica (She/Her)
Nov 9, 2024 3:24:00 GMT
Thread  
newBookmarkLockedFalling Determinants of SARS-CoV-2 within-host evolutionary rates...
Nadica (She/Her) 0 10 by Nadica (She/Her)
Nov 8, 2024 3:17:25 GMT
Thread  
newBookmarkLockedFalling Neutralizing antibody evasion of SARS-CoV-2 JN.1 derivatives
Nadica (She/Her) 0 10 by Nadica (She/Her)
Nov 7, 2024 4:25:11 GMT

Legend

Thread Announcement Sticky Locked new New Poll Bookmark

Board Information & Statistics

Board Description
Preprints (all types)
A place to park articles awaiting peer review and publishing
Board Statistics
Threads and Posts
Total Threads:264
Total Posts:265
Members
On This Board
You can create threads.
You can reply to threads.
You can create polls.
Members Online
Users Viewing
0 Staff, 0 Members, 1 Guest.